Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings

Last updated: September 9, 2025
Sponsor: Boulder Care
Overall Status: Active - Recruiting

Phase

1

Condition

Opioid Use Disorder

Treatment

Telemedicine Buprenorphine Treatment

Clinical Study ID

NCT07169409
4R44DA061386
1R44DA061386-01
  • Ages > 18
  • All Genders

Study Summary

Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business profitability.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • History of Opioid Use Disorder (OUD)

  • Starting OUD treatment with buprenorphine, or within 45 days of starting orrestarting this medication

  • Speak and understand English

Exclusion

Exclusion Criteria:

  • History of allergic reaction to buprenorphine

  • Plans to move out of a Boulder Care-affiliated state site in the next 12 months (precluding continuation of care)

  • Untreated mental or medical health conditions that, in the opinion of theparticipant, would preclude study participation

Study Design

Total Participants: 250
Treatment Group(s): 1
Primary Treatment: Telemedicine Buprenorphine Treatment
Phase: 1
Study Start date:
June 10, 2025
Estimated Completion Date:
September 15, 2027

Connect with a study center

  • Boulder Care

    Portland 5746545, Oregon 5744337 97204
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.